58
Participants
Start Date
October 31, 1999
Study Completion Date
December 31, 2004
Fabrazyme (agalsidase beta)
Mount Sinai School of Medicine, New York
University of Rochester School of Medicine, Rochester
Greater Baltimore Medical Center, Baltimore
Hart Family Practice, Hickory
Northwest Oncology & Hematology Associates, Coral Springs
University of Iowa Hospital and Clinics, Iowa City
Fetal Diagnostic and Imaging Center, Billings
Children's Memorial Hospital, Chicago
Hematology/Oncology Associates of South Texas, San Antonio
University of New Mexico, Albuquerque
Cedars-Sinai Medical Center, Los Angeles
University of California San Fransisco, San Francisco
University of Washington School of Medicine, Seattle
Beth Israel Deaconess Medical Center, Boston
Hospital Edouard Herriot, Lyon
Hospital Europeen Georges Pompidou, Paris
Academisch Medisch Centrum, Amsterdam
University of Puerto Rico, San Juan
National Hospital for Neurology and Neurosurgery, London
Hope Hospital, Manchester
Genzyme, a Sanofi Company
INDUSTRY